Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association between Urinary Cadmium and All Cause, All Cancer and Prostate Cancer Specific Mortalities for Men: an Analysis of National Health and Nutrition Examination Survey (NHANES III) Data

  • Cheung, Min Rex (FROS Radiation Oncology Cyberknife Center of New York) ;
  • Kang, Josephine (FROS Radiation Oncology Cyberknife Center of New York) ;
  • Ouyang, Daniel (FROS Radiation Oncology Cyberknife Center of New York) ;
  • Yeung, Vincent (FROS Radiation Oncology Cyberknife Center of New York)
  • Published : 2014.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Aim: This study employed public use National Health and Nutrition Examination Survey (NHANES III) data to investigate the association between urinary cadmium (UDPSI) and all cause, all cancer and prostate cancer mortalities in men. Patients and Methods: NHANES III household adult, laboratory and mortality data were merged. The sampling weight used was WTPFEX6, with SDPPSU6 applied for the probability sampling unit and SDPSTRA6 to designate the strata for the survey analysis. Results: For prostate cancer death, the significant univariates were UDPSI, age, weight, and drinking. Under multivariate logistic regression, the significant covariates were age and weight. For all cause mortality in men, the significant covariates were UDPSI, age, and poverty income ratio. For all cancer mortality in men, the significant covariates were UDPSI, age, black and Mexican race. Conclusions: UDPSI was a predictor of all cause and all cancer mortalities in men as well as prostate cancer mortality.

Keywords

References

  1. Aimola P, Carmignani M, Volpe AR, et al. (2012). Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One, 7, e33647. https://doi.org/10.1371/journal.pone.0033647
  2. Chang SL, Harshman LC, and Presti JC Jr. (2010). Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey. J Clin Oncol, 28, 3951-7. https://doi.org/10.1200/JCO.2009.27.9406
  3. Cheung R. (2012). Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: A US SEER data analysis. Asian Pac J Cancer Prev, 13, 4587-91. https://doi.org/10.7314/APJCP.2012.13.9.4587
  4. Cohen SB (1997). An evaluation of alternative PC-based packages for the analysis of complex survey data. The American Statistician, 51, 285-92.
  5. Cui Y, Winton MI, Zhang ZF, et al. (2004). Dietary boron intake and prostate cancer risk. Oncol Rep, 11, 887-92.
  6. Dahiya R, Lee C, Haughney PC, et al (1996). Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines. Urology, 48, 963-70. https://doi.org/10.1016/S0090-4295(96)00376-7
  7. Ezzati-Rice TM, Murphy RS (1995). Issues associated with the design of a national probability sample for human exposure assessment. Environ Health Perspect, 103 Suppl 3, 55-59. https://doi.org/10.1289/ehp.95103s655
  8. Graubard BI, Korn EL (1999). Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst, 91, 1005-16. https://doi.org/10.1093/jnci/91.12.1005
  9. Huff J, Lunn RM, Waalkes MP, Tomatis L, and Infante PF. (2007). Cadmium-induced cancers in animals and in humans. Int J Occup Environ Health, 13, 202-2. https://doi.org/10.1179/oeh.2007.13.2.202
  10. Jewell NP. (2004). Statistics for Epidemiology, Boca Raton, Florida: Champman & Hall/CRC.
  11. Julin B, Wolk A, Johansson JE, et al (2012). Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study. Br J Cancer, 107, 895-900. https://doi.org/10.1038/bjc.2012.311
  12. Lacher DA, Thompson TD, Hughes JP, Saraiya M. (2006). Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04. Adv Data, ??, 1-12.
  13. Lemeshow S, and Cook ED. (1999). Practical considerations in the analysis of complex sample survey data. Rev Epidemiol Sante Publique, 47, 479-487.
  14. Lin YS, Caffrey JL, Lin JW, et al (2013). Increased risk of cancer mortality associated with cadmium exposures in older americans with low zinc intake. J Toxicol Environ Health, A 76, 1-15. https://doi.org/10.1080/15287394.2012.722185
  15. Menke A, Guallar E, Rohrmann S, et al (2010). Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol, 171, 583-592. https://doi.org/10.1093/aje/kwp415
  16. Mondul AM, Rohrmann S, Menke A, et al. (2011). Association of serum alpha-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control, 22, 827-836. https://doi.org/10.1007/s10552-011-9753-4
  17. Mondul AM, Selvin E, Rohrmann S, et al (2010). Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III. Cancer Causes Control, 21, 1575-83. https://doi.org/10.1007/s10552-010-9586-6
  18. Parekh N, Lin Y, Dipaola RS, Marcella S, Lu-Yao G (2010). Obesity and prostate cancer detection: insights from three national surveys. Am J Med, 123, 829-35. https://doi.org/10.1016/j.amjmed.2010.05.011
  19. Rohrmann S, Giovannucci E, Smit E, Platz EA (2007a). Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third National Health and Nutrition Examination Survey. Prostate, 67, 1693-8. https://doi.org/10.1002/pros.20659
  20. Rohrmann S, Nelson WG, Rifai N, et al (2007b). Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab, 92, 2519-25. https://doi.org/10.1210/jc.2007-0028
  21. Rothman KJ, Greenland S, Lash TL (2008). Modern Epidemiology, 3rd edn (Philadelphia, Pennsylvania: Lippincott Williams & Wilkins).
  22. Satarug S (2012). Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinoma. Curr Drug Metab, 13, 257-71. https://doi.org/10.2174/138920012799320446
  23. Shand RL, Gelmann EP. (2006). Molecular biology of prostatecancer pathogenesis. Curr Opin Urology, 16, 123-31. https://doi.org/10.1097/01.mou.0000193384.39351.64
  24. Shiels MS, Rohrmann S, Menke A, et al (2009). Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control, 20, 877-86. https://doi.org/10.1007/s10552-009-9318-y
  25. Siegel R, Desantis C, Virgo K, et al (2012). Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 62, 220-41. https://doi.org/10.3322/caac.21149
  26. Strom SS, Kamat AM, Gruschkus SK, et al. (2006). Influence of obesity on biochemical and clinical failure after externalbeam radiotherapy for localized prostate cancer. Cancer, 107, 631-9. https://doi.org/10.1002/cncr.22025
  27. Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005). Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr, 81, 1147-54.
  28. van Wijngaarden E, Singer EA, and Palapattu GS. (2008). Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey. Prostate, 68, 122-8. https://doi.org/10.1002/pros.20668

Cited by

  1. Mechanisms of Cadmium Carcinogenicity in the Gastrointestinal Tract vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.9
  2. Investigating the Incidence of Prostate Cancer in Iran 2005-2008 using Bayesian Spatial Ecological Regression Models vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5917
  3. Association of total cancer and lung cancer with environmental exposure to cadmium: the meta-analytical evidence vol.26, pp.9, 2015, https://doi.org/10.1007/s10552-015-0621-5
  4. Association of Urinary Cadmium with Mortality in Patients at a Coronary Care Unit vol.11, pp.1, 2016, https://doi.org/10.1371/journal.pone.0146173
  5. Factors affecting the variability in the observed levels of urinary cadmium among children and nonsmoker adolescents vol.24, pp.3, 2017, https://doi.org/10.1007/s11356-016-8008-z
  6. Factors affecting the variability in the observed levels of cadmium in blood and urine among former and current smokers aged 20-64 and ≥ 65years vol.24, pp.9, 2017, https://doi.org/10.1007/s11356-017-8607-3
  7. Role of connexin 43 in cadmium-induced proliferation of human prostate epithelial cells vol.37, pp.8, 2017, https://doi.org/10.1002/jat.3441